RPG Radiology Limited 11926868 false 2022-03-31 2023-03-29 2023-03-29 The principal activity of the company is that of radiography consultancy services. Digita Accounts Production Advanced 6.30.9574.0 true true 11926868 2022-03-31 2023-03-29 11926868 2023-03-29 11926868 bus:OrdinaryShareClass1 2023-03-29 11926868 bus:OrdinaryShareClass2 2023-03-29 11926868 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-29 11926868 core:FurnitureFittingsToolsEquipment 2023-03-29 11926868 bus:SmallEntities 2022-03-31 2023-03-29 11926868 bus:AuditExemptWithAccountantsReport 2022-03-31 2023-03-29 11926868 bus:FullAccounts 2022-03-31 2023-03-29 11926868 bus:SmallCompaniesRegimeForAccounts 2022-03-31 2023-03-29 11926868 bus:RegisteredOffice 2022-03-31 2023-03-29 11926868 bus:Director1 2022-03-31 2023-03-29 11926868 bus:OrdinaryShareClass1 2022-03-31 2023-03-29 11926868 bus:OrdinaryShareClass2 2022-03-31 2023-03-29 11926868 bus:PrivateLimitedCompanyLtd 2022-03-31 2023-03-29 11926868 core:FurnitureFittingsToolsEquipment 2022-03-31 2023-03-29 11926868 core:OfficeEquipment 2022-03-31 2023-03-29 11926868 countries:EnglandWales 2022-03-31 2023-03-29 11926868 2022-03-30 11926868 core:FurnitureFittingsToolsEquipment 2022-03-30 11926868 2021-04-01 2022-03-30 11926868 2022-03-30 11926868 bus:OrdinaryShareClass1 2022-03-30 11926868 bus:OrdinaryShareClass2 2022-03-30 11926868 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-30 11926868 core:FurnitureFittingsToolsEquipment 2022-03-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 11926868

RPG Radiology Limited

Annual Report and Unaudited Financial Statements

for the Period from 31 March 2022 to 29 March 2023

 

RPG Radiology Limited

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 6

 

RPG Radiology Limited

(Registration number: 11926868)
Balance Sheet as at 29 March 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

2,543

1,852

Current assets

 

Cash at bank and in hand

 

95,039

97,393

Creditors: Amounts falling due within one year

5

(17,256)

(73,221)

Net current assets

 

77,783

24,172

Total assets less current liabilities

 

80,326

26,024

Provisions for liabilities

(596)

(352)

Net assets

 

79,730

25,672

Capital and reserves

 

Called up share capital

6

100

100

Retained earnings

79,630

25,572

Shareholders' funds

 

79,730

25,672

For the financial period ending 29 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006 and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account and director's report have not been delivered in accordance with the special provisions applicable to companies subject to the small companies regime.

Approved and authorised by the director on 1 March 2024
 

.........................................
Dr JM Howard
Director

 

RPG Radiology Limited

Notes to the Unaudited Financial Statements for the Period from 31 March 2022 to 29 March 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
10 Wellington Street (St. Johns)
Blackburn
Lancashire
BB1 8AG
United Kingdom

These financial statements were authorised for issue by the director on 1 March 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are presented in Sterling which is the functional currency of the company and the accounts are rounded to the nearest pound.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

RPG Radiology Limited

Notes to the Unaudited Financial Statements for the Period from 31 March 2022 to 29 March 2023

Government grants

The company has received a revenue grant in the form of the Job Retention Scheme in respect of furloughed staff. Revenue grants are credited to the profit and loss account so as to match them with the expenditure to which they relate.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings and equipment

15% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

RPG Radiology Limited

Notes to the Unaudited Financial Statements for the Period from 31 March 2022 to 29 March 2023

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which employee's services are received.

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 2 (2022 - 2).

 

RPG Radiology Limited

Notes to the Unaudited Financial Statements for the Period from 31 March 2022 to 29 March 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 31 March 2022

2,845

2,845

Additions

1,139

1,139

At 29 March 2023

3,984

3,984

Depreciation

At 31 March 2022

993

993

Charge for the period

448

448

At 29 March 2023

1,441

1,441

Carrying amount

At 29 March 2023

2,543

2,543

At 30 March 2022

1,852

1,852

5

Creditors

Creditors: amounts falling due within one year

2023
£

2022
£

Due within one year

Taxation and social security

14,841

13,506

Accruals and deferred income

2,400

1,800

Other creditors

15

57,915

17,256

73,221

 

RPG Radiology Limited

Notes to the Unaudited Financial Statements for the Period from 31 March 2022 to 29 March 2023

6

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary A of £1 each

50

50

50

50

Ordinary B of £1 each

50

50

50

50

 

100

100

100

100